Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of DENTSPLY SIRONA Inc (NASDAQ: XRAY) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of DENTSPLY SIRONA Inc (NASDAQ: XRAY)  concerning whether a series of statements by DENTSPLY SIRONA Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 9, 2017, the Company revealed second quarter 2017 earnings that fell below expectations, as well as a U.S. Securities and Exchange Commission investigation "concerning the Company's accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company."

Following this news, NASDAQ: XRAY dropped $5.18, or 8.44%, to close at $56.23 on August 9, 2017.

Based in York, Pennsylvania, and founded in 1899 DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.

If you purchased shares of DENTSPLY SIRONA Inc (NASDAQ: XRAY) on or before August 9, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185